Bristol's $250,000 Pill Slows Lung Cancer Growth by Seven Weeks bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Bristol Myers Squibb is presenting data from more than 130 studies on 25 types of cancer and serious blood disorders at ASCO and EHA.The group has announced the presentation of data from its oncology.
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting